Botox Cosmetic (onabotulinumtoxinA) just became the only FDA approved drug treatment option for the temporary improvement in the appearance of moderate to severe crow’s feet, in adults.
The FDA approved Botox Cosmetic in 2002 for the temporary improvement of frown lines in the brow. Injections for both can be given simultaneously.
“This additional indication will provide people with a new FDA approved treatment option for those seeking a smoother appearance by temporarily minimizing the appearance of crow’s feet at the sides of the eyes,” said Susan Walker, M.D., director of the Division of Dermatology and Dental Products in the FDA’s Center for Drug Evaluation and Research.
Botox and Botox Cosmetic, have also been approved by the FDA for the treatment of chronic migraine, severe underarm sweating, eyelid spasm (blepharospasm) and misalignment of the eyes when one or both eyes turn inward or outward (strabismus).
The most common adverse reaction associated with the use of Botox Cosmetic for treatment of lateral canthal lines crow’s feet) is eyelid edema, a condition in which the eyelids become swollen and contain excessive fluid. However, both come with boxed warnings stating that “the effects of the botulinum toxin may spread from the area of injection to other areas of the body, causing symptoms similar to those of botulism” These include swallowing and breathing difficulties that can be life-threatening.
Anyone experiencing adverse reactions from the use of Botox Cosmetic can report them to the FDA’s MedWatch Adverse Event Reporting program at www.fda.gov/MedWatch2 or by calling 800-FDA-1088.